## Early treatment of acute hepatitis C infection with interferon alfa-2b (IFN -β£-2b) prevents chronicity in almost all patients. So far, no data are available on the long-term outcome after interferon (IFN) therapy of acute hepatitis C. The aim of this study was to assess the clinical, virologica
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
β Scribed by Stephen A. Villano; David Vlahov; Kenrad E. Nelson; Sylvia Cohn; David L. Thomas
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 83 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To estimate the long-term persistence of anti-HAV antibodies, 120 (schedule 0-6) and 194 (schedule 0-12) adults were vaccinated and followed-up annually for 6 years. Shortly after the last dose, anti-HAV levels fell sharply (annual decline rate delta > 65%). Thereafter, delta diminished to 10-15%. G
Carrier states without significant laboratory abnormali-We analyzed the long-term clinical course of 71 paties are observed in approximately 16%, biochemical abtients with RNA-positive hepatitis C virus (HCV) infecnormalities without symptoms are seen in 60%, and tion after liver transplantation. Pa
## Abstract An attempt was made to identify factors influencing the cumulative probability of an increased alanine aminotransferase (ALT) level and hepatocarcinogenesis in hepatitis C patients with a normal ALT level initially. A total of 398 consecutive patients with a normal ALT level initially f
We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986